Advertisement Study suggests Lunesta improves sleep in menopausal women - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Study suggests Lunesta improves sleep in menopausal women

Sepracor has released results from a late phase study that show its insomnia drug, Lunesta, significantly improved sleep for menopausal women suffering from insomnia.

In the study, nightly use of Lunesta resulted in statistically significant improvement, compared with placebo, in patient-reported measures of sleep. Women treated with Lunesta reported fewer nocturnal awakenings due to hot flashes than those treated with placebo. The drug was also well tolerated over the treatment period.

“More than 1.3 million women become menopausal each year in the US, adding to the existing 40 million American women of menopausal age who are already going through various neuroendocrine and somatic changes. Those changes may frequently be accompanied by symptoms of insomnia such as waking up during the night and difficulty falling back to sleep, particularly in the presence of hot flashes,” said Dr Claudio Soares, associate professor at McMaster University.

According to the Agency for Healthcare Research and Quality, up to 40-60% of perimenopausal, menopausal, and postmenopausal women experience sleep disturbances.